Pfizer Japan Launches J ZOLOFT Tablets SSRI Antidepressant.
Tokyo, Japan, July 12, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) ) - Pfizer Japan introduced J ZOLOFT Tablets 25mg/50mg, its proprietary antidepressant, on July 7.
J ZOLOFT, a selective serotonin reuptake inhibitor selective serotonin reuptake inhibitor
n.
SSRI.
Selective serotonin reuptake inhibitor (SSRI)
A class of antidepressants that work by blocking the reabsorption of serotonin in the brain, raising the levels of (SSRI SSRI selective serotonin reuptake inhibitor.
SSRI
n.
Selective serotonin reuptake inhibitor; a class of drugs that inhibit the reuptake of serotonin in the central nervous system, used to treat depression and other ) developed by Pfizer of the US, was initially approved in the UK in 1990 and is now available in 110 countries worldwide.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion